Buscar resultados de ensayos clínicos

Patrocinado por

Chiari Malformation Type 2 - 22 Studies Found

Estado Estudiar
Completed Nombre del estudio: Open-Label Safety Study to Evaluate Imiquimod Cream, 5% for Large Areas of Actinic Keratosis
Condición: Keratosis
Fecha: 2005-06-30
Intervenciones: Drug: imiquimod cream imiquimod 5% cream applied in doses ranging from one packet (12.5 mg) to 6 packets
Completed Nombre del estudio: Study in Healthy Volunteers to Prove That Two Different Formulations of Rotigotine Patches Deliver Equivalent Drug Amount to the Body
Condición: Healthy Volunteers
Fecha: 2010-01-28
Intervenciones: Drug: Rotigotine transdermal patch Rotigotine 4.5 mg/10 cm^2 patch applied for 24 hours
Completed Nombre del estudio: A 24 Week, Multicenter, Open, Evaluation of the Clinical Effectiveness of the Once-daily 10 cm^2 Rivastigmine Patch Formulation in Patients With Probable Alzheimer's Disease (EXTRA)
Condición: Alzheimer's Disease
Fecha: 2008-02-14
Intervenciones: Drug: Rivastigmine transdermal patch The study treatment was delivered as a patch sizes 5 and 10 cm^2 co
Completed Nombre del estudio: A Study of Increasing Strengths, Safety and Efficacy of Two Formulas of LEO 43204 on the Face or the Chest in Patients With Actinic Keratosis
Condición: Actinic Keratosis
Fecha: 2013-08-12
Intervenciones:
  • Drug: LEO 43204 Formulation 1
  • Drug: LEO 43
Completed Nombre del estudio: Study to Evaluate the Pharmacokinetics (PK), Safety, Tolerability of Single-Dose Transdermal Rotigotine in Japanese and Caucasian Healthy Male / Female Subjects
Condición: Healthy
Fecha: 2013-01-03
Intervenciones: Drug: Rotigotine transdermal patch Rotigotine transdermal patch, single-dose application over 24 hours 2
Completed Nombre del estudio: Bioequivalence of Testosterone Reduced-size Patch Relative to the Testosterone Reference Patch
Condición: Healthy
Fecha: 2008-11-14
Intervenciones:
  • Drug: testosterone 28 cm2 test
Completed Nombre del estudio: Safety and Efficacy of Doses of Ingenol Mebutate Once Daily for Two or Three Consecutive Days in Subjects With Actinic Keratosis
Condición: Actinic Keratosis
Fecha: 2013-03-25
Intervenciones:
  • Drug: Ingenol mebutate gel
  • Drug: placebo
Completed Nombre del estudio: Pharmacokinetics, Metabolism, Efficacy, and Safety Study of Two Testosterone Matrix Transdermal Systems
Condición: Hypogonadism
Fecha: 2011-03-21
Intervenciones: Drug: testosterone matrix transdermal system
Completed Nombre del estudio: A Study to Determine the Optimal Tolerated Regime and Safety of PEP005 Topical Gel
Condición: Actinic Keratoses
Fecha: 2007-01-24
Intervenciones: Drug: PEP005
Completed Nombre del estudio: Corneal Cross-Linking Comparing Variables
Condición: Unstable Corneas
Fecha: 2014-03-20
Intervenciones:
  • Drug: Epithelium-On Riboflavin

<<< Previous | Next >>>